nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—CYSLTR2—cardiovascular system—coronary artery disease	0.0115	0.175	CbGeAlD
Nedocromil—HSP90AA1—endothelium—coronary artery disease	0.00911	0.139	CbGeAlD
Nedocromil—FPR1—blood—coronary artery disease	0.00817	0.124	CbGeAlD
Nedocromil—PTGDR—blood—coronary artery disease	0.00772	0.117	CbGeAlD
Nedocromil—HSP90AA1—cardiac ventricle—coronary artery disease	0.00605	0.0921	CbGeAlD
Nedocromil—HSP90AA1—myocardium—coronary artery disease	0.00569	0.0866	CbGeAlD
Nedocromil—HSP90AA1—heart—coronary artery disease	0.00397	0.0604	CbGeAlD
Nedocromil—HSP90AA1—cardiovascular system—coronary artery disease	0.00375	0.057	CbGeAlD
Nedocromil—CYSLTR1—blood—coronary artery disease	0.00342	0.052	CbGeAlD
Nedocromil—HSP90AA1—cardiac atrium—coronary artery disease	0.0034	0.0517	CbGeAlD
Nedocromil—HSP90AA1—blood—coronary artery disease	0.00297	0.0451	CbGeAlD
Nedocromil—Dyspnoea—Perindopril—coronary artery disease	0.000346	0.000773	CcSEcCtD
Nedocromil—Body temperature increased—Niacin—coronary artery disease	0.000346	0.000773	CcSEcCtD
Nedocromil—Abdominal pain—Niacin—coronary artery disease	0.000346	0.000773	CcSEcCtD
Nedocromil—Dizziness—Fenofibrate—coronary artery disease	0.000345	0.000771	CcSEcCtD
Nedocromil—Fatigue—Captopril—coronary artery disease	0.000345	0.00077	CcSEcCtD
Nedocromil—Leukopenia—Ramipril—coronary artery disease	0.000343	0.000765	CcSEcCtD
Nedocromil—Urticaria—Pravastatin—coronary artery disease	0.000343	0.000765	CcSEcCtD
Nedocromil—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000343	0.000764	CcSEcCtD
Nedocromil—Asthenia—Simvastatin—coronary artery disease	0.000342	0.000764	CcSEcCtD
Nedocromil—Diarrhoea—Ezetimibe—coronary artery disease	0.000342	0.000764	CcSEcCtD
Nedocromil—Dyspepsia—Perindopril—coronary artery disease	0.000342	0.000763	CcSEcCtD
Nedocromil—Gastrointestinal pain—Enalapril—coronary artery disease	0.000341	0.000761	CcSEcCtD
Nedocromil—Abdominal pain—Pravastatin—coronary artery disease	0.000341	0.000761	CcSEcCtD
Nedocromil—Body temperature increased—Pravastatin—coronary artery disease	0.000341	0.000761	CcSEcCtD
Nedocromil—Dysgeusia—Lisinopril—coronary artery disease	0.00034	0.000759	CcSEcCtD
Nedocromil—Dizziness—Clopidogrel—coronary artery disease	0.00034	0.000758	CcSEcCtD
Nedocromil—Dizziness—Lovastatin—coronary artery disease	0.000337	0.000753	CcSEcCtD
Nedocromil—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000336	0.000751	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000335	0.000749	CcSEcCtD
Nedocromil—Diarrhoea—Eplerenone—coronary artery disease	0.000335	0.000748	CcSEcCtD
Nedocromil—Fatigue—Perindopril—coronary artery disease	0.000335	0.000747	CcSEcCtD
Nedocromil—Cough—Ramipril—coronary artery disease	0.000334	0.000746	CcSEcCtD
Nedocromil—Urticaria—Trandolapril—coronary artery disease	0.000333	0.000743	CcSEcCtD
Nedocromil—Pain—Perindopril—coronary artery disease	0.000332	0.000741	CcSEcCtD
Nedocromil—Vomiting—Fenofibrate—coronary artery disease	0.000332	0.000741	CcSEcCtD
Nedocromil—Hypersensitivity—Valsartan—coronary artery disease	0.000332	0.000741	CcSEcCtD
Nedocromil—Urticaria—Enalapril—coronary artery disease	0.000331	0.00074	CcSEcCtD
Nedocromil—Body temperature increased—Trandolapril—coronary artery disease	0.000331	0.000739	CcSEcCtD
Nedocromil—Abdominal pain—Trandolapril—coronary artery disease	0.000331	0.000739	CcSEcCtD
Nedocromil—Dizziness—Ezetimibe—coronary artery disease	0.000331	0.000738	CcSEcCtD
Nedocromil—Abdominal pain—Enalapril—coronary artery disease	0.00033	0.000736	CcSEcCtD
Nedocromil—Body temperature increased—Enalapril—coronary artery disease	0.00033	0.000736	CcSEcCtD
Nedocromil—Rash—Fenofibrate—coronary artery disease	0.000329	0.000735	CcSEcCtD
Nedocromil—Dermatitis—Fenofibrate—coronary artery disease	0.000329	0.000734	CcSEcCtD
Nedocromil—Headache—Fenofibrate—coronary artery disease	0.000327	0.00073	CcSEcCtD
Nedocromil—Gastrointestinal pain—Captopril—coronary artery disease	0.000327	0.00073	CcSEcCtD
Nedocromil—Urticaria—Telmisartan—coronary artery disease	0.000327	0.00073	CcSEcCtD
Nedocromil—Cough—Timolol—coronary artery disease	0.000327	0.000729	CcSEcCtD
Nedocromil—Vomiting—Clopidogrel—coronary artery disease	0.000326	0.000729	CcSEcCtD
Nedocromil—Diarrhoea—Simvastatin—coronary artery disease	0.000326	0.000729	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000326	0.000728	CcSEcCtD
Nedocromil—Chest pain—Ramipril—coronary artery disease	0.000326	0.000727	CcSEcCtD
Nedocromil—Fatigue—Furosemide—coronary artery disease	0.000326	0.000727	CcSEcCtD
Nedocromil—Tremor—Lisinopril—coronary artery disease	0.000325	0.000726	CcSEcCtD
Nedocromil—Abdominal pain—Telmisartan—coronary artery disease	0.000325	0.000726	CcSEcCtD
Nedocromil—Body temperature increased—Telmisartan—coronary artery disease	0.000325	0.000726	CcSEcCtD
Nedocromil—Dyspnoea—Losartan—coronary artery disease	0.000325	0.000725	CcSEcCtD
Nedocromil—Vomiting—Lovastatin—coronary artery disease	0.000324	0.000724	CcSEcCtD
Nedocromil—Dizziness—Eplerenone—coronary artery disease	0.000324	0.000723	CcSEcCtD
Nedocromil—Rash—Clopidogrel—coronary artery disease	0.000324	0.000723	CcSEcCtD
Nedocromil—Dermatitis—Clopidogrel—coronary artery disease	0.000323	0.000722	CcSEcCtD
Nedocromil—Asthenia—Valsartan—coronary artery disease	0.000323	0.000721	CcSEcCtD
Nedocromil—Pain—Furosemide—coronary artery disease	0.000323	0.000721	CcSEcCtD
Nedocromil—Hypersensitivity—Niacin—coronary artery disease	0.000323	0.00072	CcSEcCtD
Nedocromil—Asthenia—Olmesartan—coronary artery disease	0.000322	0.000718	CcSEcCtD
Nedocromil—Headache—Clopidogrel—coronary artery disease	0.000322	0.000718	CcSEcCtD
Nedocromil—Rash—Lovastatin—coronary artery disease	0.000322	0.000718	CcSEcCtD
Nedocromil—Dermatitis—Lovastatin—coronary artery disease	0.000321	0.000717	CcSEcCtD
Nedocromil—Dyspepsia—Losartan—coronary artery disease	0.000321	0.000716	CcSEcCtD
Nedocromil—Headache—Lovastatin—coronary artery disease	0.00032	0.000713	CcSEcCtD
Nedocromil—Dry mouth—Ramipril—coronary artery disease	0.000319	0.000711	CcSEcCtD
Nedocromil—Chest pain—Timolol—coronary artery disease	0.000319	0.000711	CcSEcCtD
Nedocromil—Vomiting—Ezetimibe—coronary artery disease	0.000318	0.00071	CcSEcCtD
Nedocromil—Hypersensitivity—Pravastatin—coronary artery disease	0.000318	0.000709	CcSEcCtD
Nedocromil—Gastrointestinal pain—Perindopril—coronary artery disease	0.000318	0.000709	CcSEcCtD
Nedocromil—Abdominal pain—Captopril—coronary artery disease	0.000316	0.000706	CcSEcCtD
Nedocromil—Body temperature increased—Captopril—coronary artery disease	0.000316	0.000706	CcSEcCtD
Nedocromil—Dizziness—Simvastatin—coronary artery disease	0.000316	0.000704	CcSEcCtD
Nedocromil—Rash—Ezetimibe—coronary artery disease	0.000315	0.000704	CcSEcCtD
Nedocromil—Dermatitis—Ezetimibe—coronary artery disease	0.000315	0.000703	CcSEcCtD
Nedocromil—Asthenia—Niacin—coronary artery disease	0.000314	0.000701	CcSEcCtD
Nedocromil—Fatigue—Losartan—coronary artery disease	0.000314	0.000701	CcSEcCtD
Nedocromil—Headache—Ezetimibe—coronary artery disease	0.000313	0.000699	CcSEcCtD
Nedocromil—Anaphylactic shock—Ramipril—coronary artery disease	0.000312	0.000697	CcSEcCtD
Nedocromil—Dry mouth—Timolol—coronary artery disease	0.000312	0.000695	CcSEcCtD
Nedocromil—Pain—Losartan—coronary artery disease	0.000312	0.000695	CcSEcCtD
Nedocromil—Vomiting—Eplerenone—coronary artery disease	0.000311	0.000695	CcSEcCtD
Nedocromil—Leukopenia—Lisinopril—coronary artery disease	0.000311	0.000694	CcSEcCtD
Nedocromil—Nausea—Fenofibrate—coronary artery disease	0.00031	0.000692	CcSEcCtD
Nedocromil—Asthenia—Pravastatin—coronary artery disease	0.000309	0.000691	CcSEcCtD
Nedocromil—Gastrointestinal pain—Furosemide—coronary artery disease	0.000309	0.000689	CcSEcCtD
Nedocromil—Rash—Eplerenone—coronary artery disease	0.000309	0.000689	CcSEcCtD
Nedocromil—Urticaria—Perindopril—coronary artery disease	0.000309	0.000689	CcSEcCtD
Nedocromil—Hypersensitivity—Trandolapril—coronary artery disease	0.000309	0.000689	CcSEcCtD
Nedocromil—Dermatitis—Eplerenone—coronary artery disease	0.000308	0.000688	CcSEcCtD
Nedocromil—Diarrhoea—Valsartan—coronary artery disease	0.000308	0.000688	CcSEcCtD
Nedocromil—Hypersensitivity—Enalapril—coronary artery disease	0.000307	0.000686	CcSEcCtD
Nedocromil—Abdominal pain—Perindopril—coronary artery disease	0.000307	0.000685	CcSEcCtD
Nedocromil—Body temperature increased—Perindopril—coronary artery disease	0.000307	0.000685	CcSEcCtD
Nedocromil—Diarrhoea—Olmesartan—coronary artery disease	0.000307	0.000685	CcSEcCtD
Nedocromil—Headache—Eplerenone—coronary artery disease	0.000307	0.000685	CcSEcCtD
Nedocromil—Anaphylactic shock—Timolol—coronary artery disease	0.000305	0.000682	CcSEcCtD
Nedocromil—Nausea—Clopidogrel—coronary artery disease	0.000305	0.000681	CcSEcCtD
Nedocromil—Vomiting—Simvastatin—coronary artery disease	0.000303	0.000677	CcSEcCtD
Nedocromil—Hypersensitivity—Telmisartan—coronary artery disease	0.000303	0.000677	CcSEcCtD
Nedocromil—Cough—Lisinopril—coronary artery disease	0.000303	0.000676	CcSEcCtD
Nedocromil—Nausea—Lovastatin—coronary artery disease	0.000303	0.000676	CcSEcCtD
Nedocromil—Rash—Simvastatin—coronary artery disease	0.000301	0.000671	CcSEcCtD
Nedocromil—Dermatitis—Simvastatin—coronary artery disease	0.000301	0.000671	CcSEcCtD
Nedocromil—Asthenia—Trandolapril—coronary artery disease	0.000301	0.000671	CcSEcCtD
Nedocromil—Urticaria—Furosemide—coronary artery disease	0.0003	0.00067	CcSEcCtD
Nedocromil—Diarrhoea—Niacin—coronary artery disease	0.0003	0.000669	CcSEcCtD
Nedocromil—Asthenia—Enalapril—coronary artery disease	0.000299	0.000668	CcSEcCtD
Nedocromil—Headache—Simvastatin—coronary artery disease	0.000299	0.000667	CcSEcCtD
Nedocromil—Abdominal pain—Furosemide—coronary artery disease	0.000299	0.000666	CcSEcCtD
Nedocromil—Body temperature increased—Furosemide—coronary artery disease	0.000299	0.000666	CcSEcCtD
Nedocromil—Gastrointestinal pain—Losartan—coronary artery disease	0.000298	0.000665	CcSEcCtD
Nedocromil—Dizziness—Valsartan—coronary artery disease	0.000298	0.000665	CcSEcCtD
Nedocromil—Nausea—Ezetimibe—coronary artery disease	0.000297	0.000663	CcSEcCtD
Nedocromil—Dizziness—Olmesartan—coronary artery disease	0.000297	0.000662	CcSEcCtD
Nedocromil—Chest pain—Lisinopril—coronary artery disease	0.000296	0.00066	CcSEcCtD
Nedocromil—Asthenia—Telmisartan—coronary artery disease	0.000295	0.000659	CcSEcCtD
Nedocromil—Diarrhoea—Pravastatin—coronary artery disease	0.000295	0.000659	CcSEcCtD
Nedocromil—Nausea—Eplerenone—coronary artery disease	0.000291	0.000649	CcSEcCtD
Nedocromil—Dizziness—Niacin—coronary artery disease	0.00029	0.000647	CcSEcCtD
Nedocromil—Urticaria—Losartan—coronary artery disease	0.000289	0.000646	CcSEcCtD
Nedocromil—Dry mouth—Lisinopril—coronary artery disease	0.000289	0.000645	CcSEcCtD
Nedocromil—Abdominal pain—Losartan—coronary artery disease	0.000288	0.000643	CcSEcCtD
Nedocromil—Body temperature increased—Losartan—coronary artery disease	0.000288	0.000643	CcSEcCtD
Nedocromil—Asthenia—Captopril—coronary artery disease	0.000287	0.000641	CcSEcCtD
Nedocromil—Diarrhoea—Trandolapril—coronary artery disease	0.000287	0.00064	CcSEcCtD
Nedocromil—Vomiting—Valsartan—coronary artery disease	0.000286	0.000639	CcSEcCtD
Nedocromil—Diarrhoea—Enalapril—coronary artery disease	0.000285	0.000637	CcSEcCtD
Nedocromil—Dizziness—Pravastatin—coronary artery disease	0.000285	0.000637	CcSEcCtD
Nedocromil—Vomiting—Olmesartan—coronary artery disease	0.000285	0.000636	CcSEcCtD
Nedocromil—Rash—Valsartan—coronary artery disease	0.000284	0.000634	CcSEcCtD
Nedocromil—Dermatitis—Valsartan—coronary artery disease	0.000284	0.000633	CcSEcCtD
Nedocromil—Nausea—Simvastatin—coronary artery disease	0.000283	0.000632	CcSEcCtD
Nedocromil—Anaphylactic shock—Lisinopril—coronary artery disease	0.000283	0.000632	CcSEcCtD
Nedocromil—Rash—Olmesartan—coronary artery disease	0.000283	0.000631	CcSEcCtD
Nedocromil—Dermatitis—Olmesartan—coronary artery disease	0.000282	0.00063	CcSEcCtD
Nedocromil—Headache—Valsartan—coronary artery disease	0.000282	0.00063	CcSEcCtD
Nedocromil—Diarrhoea—Telmisartan—coronary artery disease	0.000282	0.000628	CcSEcCtD
Nedocromil—Headache—Olmesartan—coronary artery disease	0.000281	0.000627	CcSEcCtD
Nedocromil—Asthenia—Perindopril—coronary artery disease	0.000279	0.000622	CcSEcCtD
Nedocromil—Dyspnoea—Ramipril—coronary artery disease	0.000279	0.000622	CcSEcCtD
Nedocromil—Vomiting—Niacin—coronary artery disease	0.000279	0.000622	CcSEcCtD
Nedocromil—Hypersensitivity—Furosemide—coronary artery disease	0.000278	0.000621	CcSEcCtD
Nedocromil—Dizziness—Trandolapril—coronary artery disease	0.000277	0.000618	CcSEcCtD
Nedocromil—Rash—Niacin—coronary artery disease	0.000276	0.000616	CcSEcCtD
Nedocromil—Dermatitis—Niacin—coronary artery disease	0.000276	0.000616	CcSEcCtD
Nedocromil—Dizziness—Enalapril—coronary artery disease	0.000276	0.000616	CcSEcCtD
Nedocromil—Dyspepsia—Ramipril—coronary artery disease	0.000275	0.000614	CcSEcCtD
Nedocromil—Headache—Niacin—coronary artery disease	0.000274	0.000612	CcSEcCtD
Nedocromil—Vomiting—Pravastatin—coronary artery disease	0.000274	0.000612	CcSEcCtD
Nedocromil—Diarrhoea—Captopril—coronary artery disease	0.000274	0.000611	CcSEcCtD
Nedocromil—Dyspnoea—Timolol—coronary artery disease	0.000272	0.000608	CcSEcCtD
Nedocromil—Dizziness—Telmisartan—coronary artery disease	0.000272	0.000607	CcSEcCtD
Nedocromil—Rash—Pravastatin—coronary artery disease	0.000272	0.000607	CcSEcCtD
Nedocromil—Dermatitis—Pravastatin—coronary artery disease	0.000272	0.000606	CcSEcCtD
Nedocromil—Asthenia—Furosemide—coronary artery disease	0.000271	0.000605	CcSEcCtD
Nedocromil—Headache—Pravastatin—coronary artery disease	0.00027	0.000603	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Ramipril—coronary artery disease	0.00027	0.000602	CcSEcCtD
Nedocromil—Fatigue—Ramipril—coronary artery disease	0.000269	0.000601	CcSEcCtD
Nedocromil—Dyspepsia—Timolol—coronary artery disease	0.000269	0.0006	CcSEcCtD
Nedocromil—Hypersensitivity—Losartan—coronary artery disease	0.000268	0.000599	CcSEcCtD
Nedocromil—Nausea—Valsartan—coronary artery disease	0.000268	0.000597	CcSEcCtD
Nedocromil—Nausea—Olmesartan—coronary artery disease	0.000266	0.000594	CcSEcCtD
Nedocromil—Vomiting—Trandolapril—coronary artery disease	0.000266	0.000594	CcSEcCtD
Nedocromil—Diarrhoea—Perindopril—coronary artery disease	0.000266	0.000593	CcSEcCtD
Nedocromil—Vomiting—Enalapril—coronary artery disease	0.000265	0.000592	CcSEcCtD
Nedocromil—Dizziness—Captopril—coronary artery disease	0.000265	0.000591	CcSEcCtD
Nedocromil—Rash—Trandolapril—coronary artery disease	0.000264	0.000589	CcSEcCtD
Nedocromil—Dermatitis—Trandolapril—coronary artery disease	0.000264	0.000589	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Timolol—coronary artery disease	0.000264	0.000589	CcSEcCtD
Nedocromil—Fatigue—Timolol—coronary artery disease	0.000263	0.000588	CcSEcCtD
Nedocromil—Rash—Enalapril—coronary artery disease	0.000263	0.000587	CcSEcCtD
Nedocromil—Dermatitis—Enalapril—coronary artery disease	0.000263	0.000586	CcSEcCtD
Nedocromil—Headache—Trandolapril—coronary artery disease	0.000262	0.000586	CcSEcCtD
Nedocromil—Vomiting—Telmisartan—coronary artery disease	0.000262	0.000584	CcSEcCtD
Nedocromil—Asthenia—Losartan—coronary artery disease	0.000261	0.000583	CcSEcCtD
Nedocromil—Headache—Enalapril—coronary artery disease	0.000261	0.000583	CcSEcCtD
Nedocromil—Pain—Timolol—coronary artery disease	0.000261	0.000583	CcSEcCtD
Nedocromil—Nausea—Niacin—coronary artery disease	0.00026	0.000581	CcSEcCtD
Nedocromil—Rash—Telmisartan—coronary artery disease	0.000259	0.000579	CcSEcCtD
Nedocromil—Dermatitis—Telmisartan—coronary artery disease	0.000259	0.000578	CcSEcCtD
Nedocromil—Diarrhoea—Furosemide—coronary artery disease	0.000258	0.000577	CcSEcCtD
Nedocromil—Headache—Telmisartan—coronary artery disease	0.000258	0.000575	CcSEcCtD
Nedocromil—Dizziness—Perindopril—coronary artery disease	0.000257	0.000573	CcSEcCtD
Nedocromil—Nausea—Pravastatin—coronary artery disease	0.000256	0.000572	CcSEcCtD
Nedocromil—Gastrointestinal pain—Ramipril—coronary artery disease	0.000256	0.00057	CcSEcCtD
Nedocromil—Vomiting—Captopril—coronary artery disease	0.000254	0.000568	CcSEcCtD
Nedocromil—Dyspnoea—Lisinopril—coronary artery disease	0.000253	0.000564	CcSEcCtD
Nedocromil—Rash—Captopril—coronary artery disease	0.000252	0.000563	CcSEcCtD
Nedocromil—Dermatitis—Captopril—coronary artery disease	0.000252	0.000563	CcSEcCtD
Nedocromil—Headache—Captopril—coronary artery disease	0.000251	0.000559	CcSEcCtD
Nedocromil—Gastrointestinal pain—Timolol—coronary artery disease	0.00025	0.000557	CcSEcCtD
Nedocromil—Dizziness—Furosemide—coronary artery disease	0.00025	0.000557	CcSEcCtD
Nedocromil—Dyspepsia—Lisinopril—coronary artery disease	0.000249	0.000557	CcSEcCtD
Nedocromil—Diarrhoea—Losartan—coronary artery disease	0.000249	0.000556	CcSEcCtD
Nedocromil—Nausea—Trandolapril—coronary artery disease	0.000249	0.000555	CcSEcCtD
Nedocromil—Urticaria—Ramipril—coronary artery disease	0.000248	0.000554	CcSEcCtD
Nedocromil—Nausea—Enalapril—coronary artery disease	0.000248	0.000553	CcSEcCtD
Nedocromil—Vomiting—Perindopril—coronary artery disease	0.000247	0.000551	CcSEcCtD
Nedocromil—Abdominal pain—Ramipril—coronary artery disease	0.000247	0.000551	CcSEcCtD
Nedocromil—Body temperature increased—Ramipril—coronary artery disease	0.000247	0.000551	CcSEcCtD
Nedocromil—Rash—Perindopril—coronary artery disease	0.000245	0.000547	CcSEcCtD
Nedocromil—Dermatitis—Perindopril—coronary artery disease	0.000245	0.000546	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000245	0.000546	CcSEcCtD
Nedocromil—Nausea—Telmisartan—coronary artery disease	0.000244	0.000545	CcSEcCtD
Nedocromil—Fatigue—Lisinopril—coronary artery disease	0.000244	0.000545	CcSEcCtD
Nedocromil—Headache—Perindopril—coronary artery disease	0.000243	0.000543	CcSEcCtD
Nedocromil—Urticaria—Timolol—coronary artery disease	0.000243	0.000542	CcSEcCtD
Nedocromil—Pain—Lisinopril—coronary artery disease	0.000242	0.000541	CcSEcCtD
Nedocromil—Body temperature increased—Timolol—coronary artery disease	0.000241	0.000539	CcSEcCtD
Nedocromil—Abdominal pain—Timolol—coronary artery disease	0.000241	0.000539	CcSEcCtD
Nedocromil—Dizziness—Losartan—coronary artery disease	0.000241	0.000538	CcSEcCtD
Nedocromil—Vomiting—Furosemide—coronary artery disease	0.00024	0.000536	CcSEcCtD
Nedocromil—Rash—Furosemide—coronary artery disease	0.000238	0.000531	CcSEcCtD
Nedocromil—Dermatitis—Furosemide—coronary artery disease	0.000238	0.000531	CcSEcCtD
Nedocromil—Nausea—Captopril—coronary artery disease	0.000238	0.00053	CcSEcCtD
Nedocromil—Headache—Furosemide—coronary artery disease	0.000237	0.000528	CcSEcCtD
Nedocromil—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000232	0.000517	CcSEcCtD
Nedocromil—Vomiting—Losartan—coronary artery disease	0.000232	0.000517	CcSEcCtD
Nedocromil—Nausea—Perindopril—coronary artery disease	0.000231	0.000515	CcSEcCtD
Nedocromil—Hypersensitivity—Ramipril—coronary artery disease	0.00023	0.000514	CcSEcCtD
Nedocromil—Rash—Losartan—coronary artery disease	0.00023	0.000513	CcSEcCtD
Nedocromil—Dermatitis—Losartan—coronary artery disease	0.00023	0.000512	CcSEcCtD
Nedocromil—Headache—Losartan—coronary artery disease	0.000228	0.000509	CcSEcCtD
Nedocromil—Urticaria—Lisinopril—coronary artery disease	0.000225	0.000502	CcSEcCtD
Nedocromil—Hypersensitivity—Timolol—coronary artery disease	0.000225	0.000502	CcSEcCtD
Nedocromil—Nausea—Furosemide—coronary artery disease	0.000224	0.000501	CcSEcCtD
Nedocromil—Asthenia—Ramipril—coronary artery disease	0.000224	0.0005	CcSEcCtD
Nedocromil—Body temperature increased—Lisinopril—coronary artery disease	0.000224	0.0005	CcSEcCtD
Nedocromil—Abdominal pain—Lisinopril—coronary artery disease	0.000224	0.0005	CcSEcCtD
Nedocromil—Asthenia—Timolol—coronary artery disease	0.000219	0.000489	CcSEcCtD
Nedocromil—Nausea—Losartan—coronary artery disease	0.000216	0.000483	CcSEcCtD
Nedocromil—Diarrhoea—Ramipril—coronary artery disease	0.000214	0.000477	CcSEcCtD
Nedocromil—Diarrhoea—Timolol—coronary artery disease	0.000209	0.000466	CcSEcCtD
Nedocromil—Hypersensitivity—Lisinopril—coronary artery disease	0.000209	0.000466	CcSEcCtD
Nedocromil—Dizziness—Ramipril—coronary artery disease	0.000207	0.000461	CcSEcCtD
Nedocromil—Asthenia—Lisinopril—coronary artery disease	0.000203	0.000454	CcSEcCtD
Nedocromil—Dizziness—Timolol—coronary artery disease	0.000202	0.000451	CcSEcCtD
Nedocromil—Vomiting—Ramipril—coronary artery disease	0.000199	0.000443	CcSEcCtD
Nedocromil—Rash—Ramipril—coronary artery disease	0.000197	0.00044	CcSEcCtD
Nedocromil—Dermatitis—Ramipril—coronary artery disease	0.000197	0.000439	CcSEcCtD
Nedocromil—Headache—Ramipril—coronary artery disease	0.000196	0.000437	CcSEcCtD
Nedocromil—Vomiting—Timolol—coronary artery disease	0.000194	0.000433	CcSEcCtD
Nedocromil—Diarrhoea—Lisinopril—coronary artery disease	0.000194	0.000433	CcSEcCtD
Nedocromil—Rash—Timolol—coronary artery disease	0.000193	0.00043	CcSEcCtD
Nedocromil—Dermatitis—Timolol—coronary artery disease	0.000192	0.000429	CcSEcCtD
Nedocromil—Headache—Timolol—coronary artery disease	0.000191	0.000427	CcSEcCtD
Nedocromil—Dizziness—Lisinopril—coronary artery disease	0.000187	0.000418	CcSEcCtD
Nedocromil—Nausea—Ramipril—coronary artery disease	0.000186	0.000414	CcSEcCtD
Nedocromil—Nausea—Timolol—coronary artery disease	0.000181	0.000405	CcSEcCtD
Nedocromil—Vomiting—Lisinopril—coronary artery disease	0.00018	0.000402	CcSEcCtD
Nedocromil—Rash—Lisinopril—coronary artery disease	0.000179	0.000399	CcSEcCtD
Nedocromil—Dermatitis—Lisinopril—coronary artery disease	0.000179	0.000398	CcSEcCtD
Nedocromil—Headache—Lisinopril—coronary artery disease	0.000178	0.000396	CcSEcCtD
Nedocromil—Nausea—Lisinopril—coronary artery disease	0.000168	0.000376	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle—CCND1—coronary artery disease	2.49e-05	5.12e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—JAK2—coronary artery disease	2.48e-05	5.11e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FGF1—coronary artery disease	2.48e-05	5.1e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EDN1—coronary artery disease	2.48e-05	5.09e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EDNRA—coronary artery disease	2.47e-05	5.07e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—LPL—coronary artery disease	2.46e-05	5.06e-05	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AKT1—coronary artery disease	2.46e-05	5.06e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CXCL8—coronary artery disease	2.46e-05	5.06e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PRKCD—coronary artery disease	2.46e-05	5.05e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL5—coronary artery disease	2.46e-05	5.05e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADRB1—coronary artery disease	2.45e-05	5.05e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CYBA—coronary artery disease	2.45e-05	5.05e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DUSP6—coronary artery disease	2.44e-05	5.03e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL2—coronary artery disease	2.44e-05	5.02e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CASP3—coronary artery disease	2.44e-05	5.01e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6R—coronary artery disease	2.43e-05	5.01e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL6—coronary artery disease	2.42e-05	4.98e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FGF1—coronary artery disease	2.42e-05	4.98e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CSF2—coronary artery disease	2.42e-05	4.98e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PLAT—coronary artery disease	2.4e-05	4.94e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—LPL—coronary artery disease	2.4e-05	4.94e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—C3—coronary artery disease	2.4e-05	4.94e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IGF1—coronary artery disease	2.4e-05	4.94e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—MAPK1—coronary artery disease	2.39e-05	4.91e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RPS6KB1—coronary artery disease	2.38e-05	4.9e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MEF2C—coronary artery disease	2.38e-05	4.9e-05	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AKT1—coronary artery disease	2.38e-05	4.89e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCND1—coronary artery disease	2.37e-05	4.88e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CASP3—coronary artery disease	2.35e-05	4.84e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—VEGFA—coronary artery disease	2.35e-05	4.82e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL6—coronary artery disease	2.34e-05	4.81e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ITGB3—coronary artery disease	2.32e-05	4.77e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL12—coronary artery disease	2.32e-05	4.77e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—BDKRB2—coronary artery disease	2.32e-05	4.77e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PPP2CA—coronary artery disease	2.31e-05	4.75e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MMP9—coronary artery disease	2.3e-05	4.74e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—BCL2L1—coronary artery disease	2.3e-05	4.73e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCND1—coronary artery disease	2.29e-05	4.71e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTP1—coronary artery disease	2.29e-05	4.7e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CRP—coronary artery disease	2.28e-05	4.7e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—PIK3CA—coronary artery disease	2.28e-05	4.7e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SERPINE1—coronary artery disease	2.28e-05	4.69e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—JUNB—coronary artery disease	2.28e-05	4.68e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—IL6—coronary artery disease	2.27e-05	4.68e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PRKCD—coronary artery disease	2.27e-05	4.67e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PLCB1—coronary artery disease	2.27e-05	4.66e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCL8—coronary artery disease	2.27e-05	4.66e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPARGC1A—coronary artery disease	2.26e-05	4.66e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—HMOX1—coronary artery disease	2.25e-05	4.64e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PPP2CA—coronary artery disease	2.25e-05	4.64e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AKT1—coronary artery disease	2.23e-05	4.6e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MMP9—coronary artery disease	2.23e-05	4.58e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CAT—coronary artery disease	2.22e-05	4.58e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HTR7—coronary artery disease	2.22e-05	4.57e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MTHFR—coronary artery disease	2.22e-05	4.56e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PRKCD—coronary artery disease	2.21e-05	4.55e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—FGF2—coronary artery disease	2.21e-05	4.54e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MAPK1—coronary artery disease	2.19e-05	4.5e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NOS3—coronary artery disease	2.18e-05	4.48e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MAPK14—coronary artery disease	2.18e-05	4.48e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HTR2A—coronary artery disease	2.17e-05	4.46e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—C3—coronary artery disease	2.16e-05	4.45e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APOB—coronary artery disease	2.16e-05	4.44e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AKT1—coronary artery disease	2.16e-05	4.44e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TGFB1—coronary artery disease	2.15e-05	4.43e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ITGAV—coronary artery disease	2.12e-05	4.35e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—JAK2—coronary artery disease	2.12e-05	4.35e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HIF1A—coronary artery disease	2.11e-05	4.35e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MAPK1—coronary artery disease	2.11e-05	4.34e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KNG1—coronary artery disease	2.11e-05	4.34e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTM1—coronary artery disease	2.1e-05	4.32e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ICAM1—coronary artery disease	2.1e-05	4.32e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6ST—coronary artery disease	2.1e-05	4.32e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AGTR1—coronary artery disease	2.1e-05	4.31e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—NFKBIA—coronary artery disease	2.08e-05	4.28e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—PIK3CA—coronary artery disease	2.07e-05	4.26e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—VEGFA—coronary artery disease	2.07e-05	4.26e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APOE—coronary artery disease	2.06e-05	4.25e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HIF1A—coronary artery disease	2.06e-05	4.24e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—LPL—coronary artery disease	2.06e-05	4.24e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AGT—coronary artery disease	2.06e-05	4.23e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL10—coronary artery disease	2.05e-05	4.21e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PLG—coronary artery disease	2.04e-05	4.2e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APOA1—coronary artery disease	2.04e-05	4.2e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—KIT—coronary artery disease	2.02e-05	4.15e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—LEP—coronary artery disease	2.01e-05	4.14e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APOE—coronary artery disease	2.01e-05	4.14e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GPX1—coronary artery disease	2.01e-05	4.14e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TNF—coronary artery disease	2.01e-05	4.14e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—VEGFA—coronary artery disease	2e-05	4.11e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APOA1—coronary artery disease	1.99e-05	4.09e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADRB2—coronary artery disease	1.99e-05	4.09e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KDR—coronary artery disease	1.97e-05	4.06e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PRKCE—coronary artery disease	1.96e-05	4.04e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAPK14—coronary artery disease	1.96e-05	4.03e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CD36—coronary artery disease	1.96e-05	4.03e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SOCS1—coronary artery disease	1.96e-05	4.03e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MAPK1—coronary artery disease	1.95e-05	4.02e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—S100B—coronary artery disease	1.95e-05	4.02e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6ST—coronary artery disease	1.94e-05	3.99e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—GSK3B—coronary artery disease	1.94e-05	3.98e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPP2CA—coronary artery disease	1.93e-05	3.98e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SOCS3—coronary artery disease	1.93e-05	3.98e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CXCL8—coronary artery disease	1.93e-05	3.97e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS2—coronary artery disease	1.92e-05	3.96e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ESR1—coronary artery disease	1.92e-05	3.95e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CREB1—coronary artery disease	1.92e-05	3.95e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KITLG—coronary artery disease	1.91e-05	3.93e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TGFBR2—coronary artery disease	1.91e-05	3.93e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FN1—coronary artery disease	1.9e-05	3.91e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—F2—coronary artery disease	1.9e-05	3.91e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TGFB1—coronary artery disease	1.9e-05	3.91e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6ST—coronary artery disease	1.89e-05	3.89e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NFKBIA—coronary artery disease	1.88e-05	3.86e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6R—coronary artery disease	1.87e-05	3.85e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MMP3—coronary artery disease	1.87e-05	3.84e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—STAT5A—coronary artery disease	1.87e-05	3.84e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AKT1—coronary artery disease	1.86e-05	3.84e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MAPK1—coronary artery disease	1.86e-05	3.84e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—KIT—coronary artery disease	1.86e-05	3.83e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAPK1—coronary artery disease	1.86e-05	3.83e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—MTHFR—coronary artery disease	1.86e-05	3.82e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CASP3—coronary artery disease	1.85e-05	3.8e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL6—coronary artery disease	1.84e-05	3.78e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TGFB1—coronary artery disease	1.83e-05	3.77e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KIT—coronary artery disease	1.82e-05	3.74e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOB—coronary artery disease	1.81e-05	3.71e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCND1—coronary artery disease	1.8e-05	3.7e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAPK1—coronary artery disease	1.8e-05	3.7e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—GSK3B—coronary artery disease	1.79e-05	3.68e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EDN1—coronary artery disease	1.78e-05	3.66e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CREB1—coronary artery disease	1.77e-05	3.65e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AGT—coronary artery disease	1.76e-05	3.63e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL5—coronary artery disease	1.76e-05	3.63e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MMP9—coronary artery disease	1.75e-05	3.59e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GSK3B—coronary artery disease	1.74e-05	3.59e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FGF1—coronary artery disease	1.74e-05	3.57e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CSF2—coronary artery disease	1.74e-05	3.57e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—POMC—coronary artery disease	1.73e-05	3.56e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CREB1—coronary artery disease	1.73e-05	3.56e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6R—coronary artery disease	1.73e-05	3.56e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APOE—coronary artery disease	1.73e-05	3.56e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—LPL—coronary artery disease	1.72e-05	3.55e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RPS6KB1—coronary artery disease	1.71e-05	3.52e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MEF2C—coronary artery disease	1.71e-05	3.52e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APOA1—coronary artery disease	1.71e-05	3.51e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—FGF2—coronary artery disease	1.7e-05	3.49e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AKT1—coronary artery disease	1.69e-05	3.48e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL2—coronary artery disease	1.69e-05	3.48e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6R—coronary artery disease	1.69e-05	3.47e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ITGB3—coronary artery disease	1.67e-05	3.43e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IGF1—coronary artery disease	1.66e-05	3.42e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—MAPK1—coronary artery disease	1.66e-05	3.41e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—JAK2—coronary artery disease	1.63e-05	3.35e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—IL6—coronary artery disease	1.62e-05	3.34e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SERPINE1—coronary artery disease	1.62e-05	3.33e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PIK3CA—coronary artery disease	1.62e-05	3.33e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PPP2CA—coronary artery disease	1.62e-05	3.33e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PIK3CA—coronary artery disease	1.62e-05	3.32e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—BCL2—coronary artery disease	1.61e-05	3.32e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PRKCD—coronary artery disease	1.59e-05	3.27e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.58e-05	3.25e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SERPINE1—coronary artery disease	1.58e-05	3.25e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VEGFA—coronary artery disease	1.57e-05	3.23e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FGF2—coronary artery disease	1.57e-05	3.23e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PIK3CA—coronary artery disease	1.56e-05	3.21e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HTR2A—coronary artery disease	1.55e-05	3.2e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—C3—coronary artery disease	1.55e-05	3.19e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS3—coronary artery disease	1.55e-05	3.18e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FGF2—coronary artery disease	1.53e-05	3.15e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOS3—coronary artery disease	1.51e-05	3.1e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPARG—coronary artery disease	1.51e-05	3.1e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—JAK2—coronary artery disease	1.5e-05	3.09e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—AKT1—coronary artery disease	1.5e-05	3.08e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—POMC—coronary artery disease	1.48e-05	3.05e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HIF1A—coronary artery disease	1.48e-05	3.05e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AGT—coronary artery disease	1.48e-05	3.03e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—JAK2—coronary artery disease	1.47e-05	3.02e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—LEP—coronary artery disease	1.45e-05	2.97e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOE—coronary artery disease	1.45e-05	2.97e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TGFB1—coronary artery disease	1.44e-05	2.96e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PIK3CA—coronary artery disease	1.44e-05	2.96e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IL6—coronary artery disease	1.43e-05	2.95e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL6—coronary artery disease	1.43e-05	2.94e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOA1—coronary artery disease	1.43e-05	2.94e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL1B—coronary artery disease	1.43e-05	2.93e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KDR—coronary artery disease	1.42e-05	2.91e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTGS2—coronary artery disease	1.41e-05	2.91e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAPK1—coronary artery disease	1.41e-05	2.9e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAPK14—coronary artery disease	1.41e-05	2.89e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL6—coronary artery disease	1.38e-05	2.84e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ESR1—coronary artery disease	1.38e-05	2.84e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FN1—coronary artery disease	1.36e-05	2.8e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—F2—coronary artery disease	1.36e-05	2.8e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6ST—coronary artery disease	1.36e-05	2.79e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ALB—coronary artery disease	1.35e-05	2.78e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NFKBIA—coronary artery disease	1.35e-05	2.77e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCL8—coronary artery disease	1.34e-05	2.75e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—AKT1—coronary artery disease	1.32e-05	2.72e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AKT1—coronary artery disease	1.32e-05	2.72e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KIT—coronary artery disease	1.3e-05	2.68e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—NOS3—coronary artery disease	1.29e-05	2.66e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AKT1—coronary artery disease	1.29e-05	2.66e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CASP3—coronary artery disease	1.28e-05	2.63e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AKT1—coronary artery disease	1.27e-05	2.62e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL6—coronary artery disease	1.27e-05	2.62e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GSK3B—coronary artery disease	1.25e-05	2.57e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCND1—coronary artery disease	1.25e-05	2.56e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—POMC—coronary artery disease	1.24e-05	2.55e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CREB1—coronary artery disease	1.24e-05	2.55e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PIK3CA—coronary artery disease	1.22e-05	2.52e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL2—coronary artery disease	1.21e-05	2.5e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6R—coronary artery disease	1.21e-05	2.49e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MMP9—coronary artery disease	1.21e-05	2.49e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF1—coronary artery disease	1.19e-05	2.46e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS2—coronary artery disease	1.18e-05	2.44e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AKT1—coronary artery disease	1.17e-05	2.41e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SERPINE1—coronary artery disease	1.13e-05	2.33e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FGF2—coronary artery disease	1.1e-05	2.26e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VEGFA—coronary artery disease	1.09e-05	2.24e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MAPK1—coronary artery disease	1.09e-05	2.23e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6—coronary artery disease	1.08e-05	2.23e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOS3—coronary artery disease	1.08e-05	2.23e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—JAK2—coronary artery disease	1.05e-05	2.16e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TGFB1—coronary artery disease	1.02e-05	2.1e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MAPK1—coronary artery disease	1e-05	2.06e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AKT1—coronary artery disease	1e-05	2.06e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TGFB1—coronary artery disease	9.98e-06	2.05e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAPK1—coronary artery disease	9.78e-06	2.01e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL8—coronary artery disease	9.6e-06	1.98e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PIK3CA—coronary artery disease	9.42e-06	1.94e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CASP3—coronary artery disease	9.19e-06	1.89e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCND1—coronary artery disease	8.95e-06	1.84e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PIK3CA—coronary artery disease	8.7e-06	1.79e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MMP9—coronary artery disease	8.69e-06	1.79e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CA—coronary artery disease	8.49e-06	1.75e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6—coronary artery disease	8.34e-06	1.72e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VEGFA—coronary artery disease	7.8e-06	1.6e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6—coronary artery disease	7.7e-06	1.58e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT1—coronary artery disease	7.7e-06	1.58e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6—coronary artery disease	7.52e-06	1.55e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CA—coronary artery disease	7.29e-06	1.5e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TGFB1—coronary artery disease	7.16e-06	1.47e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT1—coronary artery disease	7.11e-06	1.46e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAPK1—coronary artery disease	7.02e-06	1.44e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT1—coronary artery disease	6.93e-06	1.43e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CA—coronary artery disease	6.09e-06	1.25e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AKT1—coronary artery disease	5.95e-06	1.22e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6—coronary artery disease	5.4e-06	1.11e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT1—coronary artery disease	4.98e-06	1.02e-05	CbGpPWpGaD
